Research presented at the 30th American Association of Hip and Knee Surgeons Annual Meeting (AAHKS) builds on existing evidence that PREVENA™ Therapy lowers surgical site complications and readmission ...
SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s De Novo request for the PREVENA™ Incision Management ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. –80 mm Hg single-use negative wound pressure therapy had ...
Prevena (Kinetic Concepts Inc. an Acelity Company) is a wound management system that is placed over a closed surgical incision. The device applies continuous negative pressure. This helps promote ...
ST. PAUL, Minn.--(BUSINESS WIRE)--3M today announced new data demonstrating the PREVENA™ Incision Management System significantly mitigated 90-day surgical site complications (SSCs) and readmission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results